Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Lysine-specific histone demethylase 1a regulates nephron development and long-term transcriptional programming
Nicola Wanner, Julia Keller, Nastassia Liaukouskaya, Geoffroy Andrieux, Sandra D. Laufer, Manuel Rogg, Tillmann Bork, Wei Liang, Fabian Braun, Fabian Haas, Milagros N. Wong, Victor G. Puelles, Sydney E. Gies, Charlotte Meyer, Melanie Boerries, Martin Helmstädter, Oliver Kretz, Iris Hild, Eric Metzger, Roland Schüle, Wibke Bechtel-Walz, Tobias B. Huber
Nicola Wanner, Julia Keller, Nastassia Liaukouskaya, Geoffroy Andrieux, Sandra D. Laufer, Manuel Rogg, Tillmann Bork, Wei Liang, Fabian Braun, Fabian Haas, Milagros N. Wong, Victor G. Puelles, Sydney E. Gies, Charlotte Meyer, Melanie Boerries, Martin Helmstädter, Oliver Kretz, Iris Hild, Eric Metzger, Roland Schüle, Wibke Bechtel-Walz, Tobias B. Huber
View: Text | PDF
Research Article Development Nephrology

Lysine-specific histone demethylase 1a regulates nephron development and long-term transcriptional programming

  • Text
  • PDF
Abstract

Low nephron endowment constitutes a risk factor for hypertension and renal disease. Epigenetic regulation is crucial for nephron progenitor cell differentiation, affecting nephron number and renal function. The role of many epigenetic modulators, such as Lysine-specific histone demethylase 1a (LSD1 or KDM1A), remains unclear. We used Kdm1a-KO mice to demonstrate that Kdm1a depletion in nephron progenitor cells results in reduced kidney size in neonates and led to glomerulosclerosis, proteinuria, and renal cysts in adults. Notably, Kdm1a deletion in podocytes or tubular cells did not replicate these effects. CRISPR/Cas9-mediated KDM1A deletion in human kidney organoids caused cyst formation and altered gene expression, with snRNA-seq revealing downregulation of podocyte genes and upregulation of metabolic genes. The presence of noncoding RNAs indicated roles in cell proliferation. Our study reveals the critical role of Kdm1a function in nephron development and highlights its affect on transcriptional programming for long-term renal function and susceptibility to cyst formation.

Authors

Nicola Wanner, Julia Keller, Nastassia Liaukouskaya, Geoffroy Andrieux, Sandra D. Laufer, Manuel Rogg, Tillmann Bork, Wei Liang, Fabian Braun, Fabian Haas, Milagros N. Wong, Victor G. Puelles, Sydney E. Gies, Charlotte Meyer, Melanie Boerries, Martin Helmstädter, Oliver Kretz, Iris Hild, Eric Metzger, Roland Schüle, Wibke Bechtel-Walz, Tobias B. Huber

×

Figure 6

CRISPR/Cas9 LSD1 KO in human renal organoids leads to cyst formation.

Options: View larger image (or click on image) Download as PowerPoint
CRISPR/Cas9 LSD1 KO in human renal organoids leads to cyst formation.
(A...
(A) CRISPR guide RNA was designed to target exon 1 of the KDM1A gene, analogous to the mouse KO, leading to a 424 bp (KDM1A #15) or 566 bp (KDM1A #27) frame shift deletion. (B) qPCR confirmed loss of KDM1A gene expression. (C) Western blot confirmed loss of KDM1A protein production. (D) Human kidney organoids after 25 days of differentiation show regular development and differentiation of KDM1A KO organoids. Scale bars: 1,000 μm (upper panel), 200 μm (lower panel). (E) IF staining of d25 control and KO organoids shows development of structures positive for podocyte marker Nephrin and proximal tubule marker LTL. Scale bars: 50 μm. (F) Organoids at day 32 after 24h of Forskolin treatment (upper panel) and day 35 after 96h of Forskolin treatment (10 μM, lower panel) show signs of cyst development in the KDM1A-KO organoids. Scale bars: 200 μm. (G) Histological sections of organoids at d32 and d35 show cysts after Forskolin treatment in the KDM1A-KO organoids. Scale bars: 100 μm. (H) IF staining of control and KO organoids at d32 or d35 Forskolin treatment (24h or 96h) shows development of cysts in structures positive for proximal tubule marker LTL. Scale bars: 100 μm.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts